NEW YORK (GenomeWeb) – Roche announced on Sunday the expansion of its HIV Global Access Program to include early infant HIV diagnostic testing in resource-limited settings.

The HIV Global Access Program was launched in 2014 to increase access to Roche's cobas AmpliPrep/cobas TaqMan HIV-1 Test version 2.0 through special pricing provided to qualifying organizations in eligible countries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.